Colitis, Ulcerative: all 1,530 studies
Page 15 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.
- Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)CompletedNCT01033305Phase 2
- Monroe County Inflammatory Bowel Disease (IBD) RegistryCompletedNCT01032525
- Propionyl-L-Carnitine in Ulcerative ColitisCompletedNCT01026857Phase 2
- Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative ColitisCompletedNCT01020708Phase 1
- A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative ColitisStatus unknownNCT01011322Phase 2
- Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative ColitisStatus unknownNCT01010815
- Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication UseTerminatedNCT00968721
- Trial of Chinese Prescription on Ulcerative ColitisCompletedNCT00963287Not applicable
- Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative ColitisCompletedNCT00961948
- Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative ColitisCompletedNCT00951548Not applicable
- A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)TerminatedNCT00947674Phase 4
- A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative ColitisCompletedNCT00928681Phase 1
- A Study to Investigate the Ileo Neo Rectal Anastomosis Compared to the Ileo Pouch Anal Anastomosis for Patients With Ulcerative ColitisCompletedNCT00922103Not applicable
- An Investigational Study to Test Usability of the Electronic Dosing Equipment MedicpenCompletedNCT00917514
- Lactobacillus GG in Pediatric Ulcerative Colitis (UC)WithdrawnNCT00895336Phase 2
- Curcumin in Pediatric Inflammatory Bowel DiseaseCompletedNCT00889161Phase 1
- Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on TherapyCompletedNCT00867438Phase 2
- Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative ColitisTerminatedNCT00837304
- Pneumococcal Vaccination in Patients With Inflammatory Bowel DiseaseCompletedNCT00829595Not applicable
- Comparison Between Chromoendoscopy and Conventional Colonoscopy to Improve the Detection of Neoplasia in Patients With Ulcerative Colitis (UC)CompletedNCT00816491Not applicable
- Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel PopulationWithdrawnNCT00815061
- FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-CORCompletedNCT00810030Phase 3
- A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative ColitisCompletedNCT00808977Phase 2
- Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control GroupStatus unknownNCT00805428
- Synbiotic Treatment of Ulcerative Colitis PatientsCompletedNCT00803829Not applicable
- Ulcerative Colitis Relapse Prevention Trial, HypnosisCompletedNCT00798642Not applicable
- The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open LabelStatus unknownNCT00793130Not applicable
- Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's DiseaseWithdrawnNCT00783575
- ADAPT Adacolumn Pediatric Trial in Ulcerative ColitisCompletedNCT00781638Not applicable
- Fecal Biomarker Study for Patients With Ulcerative ColitisCompletedNCT00780507
- Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative ColitisCompletedNCT00767728Phase 3
- Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)CompletedNCT00747110Phase 3
- Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)CompletedNCT00746447Phase 3
- Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative ColitisCompletedNCT00744016Phase 3
- Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.CompletedNCT00737789Phase 3
- A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative ColitisCompletedNCT00729872Phase 1/2
- Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT00727324Phase 2
- Thalidomide in Pediatric Inflammatory Bowel Diseases.CompletedNCT00720538Phase 3
- The Colitis Once Daily Asacol StudyCompletedNCT00708656Phase 3
- Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative ColitisTerminatedNCT00702611Phase 4
- A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative ColitisCompletedNCT00694980Phase 1
- Managing Inflammatory Bowel DiseaseCompletedNCT00679003Not applicable
- Study of COLAL-PRED to Treat Moderate to Severe Ulcerative ColitisCompletedNCT00676832Phase 2
- Endomicroscopy in Ulcerative ColitisTerminatedNCT00659867Not applicable
- A Study of MDX-1100 in Subjects With Active Ulcerative ColitisCompletedNCT00656890Phase 2
- Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsCompletedNCT00643071Phase 3
- Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative ColitisCompletedNCT00628433Phase 1/2
- Bioequivalency Study of Balsalazide Capsules Under Fasting ConditionsCompletedNCT00618228Not applicable
- A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting ConditionsCompletedNCT00618202Not applicable
- A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel DiseaseActive, not recruitingNCT00606346
- Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative ColitisCompletedNCT00604422
- Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & CholangitisCompletedNCT00587236
- Metabolic Response to Infliximab in Pediatric Ulcerative ColitisTerminatedNCT00586807Not applicable
- Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative ColitisCompletedNCT00586599Not applicable
- Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel DiseaseCompletedNCT00586352Not applicable
- Effects of Probiotics in Patients With Ulcerative ColitisWithdrawnNCT00578799Phase 1
- Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative ColitisCompletedNCT00572585Phase 2
- Mind/Body Medicine and IBD Flare-UpCompletedNCT00568256Phase 1
- Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative ColitisCompletedNCT00548574Phase 3
- Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476CompletedNCT00545389Phase 2
- Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative ColitisCompletedNCT00542152Phase 4
- Anterior Perineal Plane for Ultra Low Anterior Resection of the RectumCompletedNCT00534131Not applicable
- Cost-effectiveness of TPMT PharmacogeneticsCompletedNCT00521950Not applicable
- Probiotics in GastroIntestinal DisordersStatus unknownNCT00510978Phase 2/3
- Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative ColitisCompletedNCT00503243Phase 3
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative ColitisWithdrawnNCT00502294Phase 3
- Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative ColitisCompletedNCT00498589Phase 2
- Assessment of Pulmonary Involvement inUlcerative Colitis by Induced SputumCompletedNCT00490048Not applicable
- Follow-Up Phone Calls After Colorectal SurgeryCompletedNCT00474097
- Post-Op Quality of Life After Colorectal SurgeryCompletedNCT00468455
- Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative ColitisCompletedNCT00463619
- GI-270384 Study In Patients With Mild To Moderate Ulcerative ColitisTerminatedNCT00457171Phase 1
- OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative ColitisCompletedNCT00449722Phase 3
- Basiliximab in Moderate to Severe Ulcerative ColitisCompletedNCT00430898Phase 2
- Open-Label Adalimumab for Ulcerative Colitis PatientsCompletedNCT00421642Phase 1
- A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis DiseaseCompletedNCT00409396Not applicable
- Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative ColitisCompletedNCT00408174Phase 3
- Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative ColitisCompletedNCT00403923
- Methods of Improvement Adherence With Therapy in Ulcerative Colitis.Status unknownNCT00398593Phase 3
- Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.CompletedNCT00374725Not applicable
- CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative ColitisCompletedNCT00366925Not applicable
- An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative ColitisTerminatedNCT00355901
- Antibiotics for the Treatment of Ulcerative ColitisCompletedNCT00355602Not applicable
- Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated DysplasiaCompletedNCT00352404Phase 3
- A Double Blind Study for the Treatment of Acute Ulcerative ColitisCompletedNCT00350415Phase 3
- Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis PatientsCompletedNCT00347048Phase 3
- Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative ColitisCompletedNCT00343850Phase 3
- Treatment With Local PPARgamma Ligand in Distal Ulcerative ColitisStatus unknownNCT00309660Phase 1/2
- Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)TerminatedNCT00307827Phase 2
- Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative ColitisCompletedNCT00303381Phase 2
- Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative ColitisCompletedNCT00299013Phase 3
- Therapeutic Study of ONO-4819CD for Ulcerative ColitisTerminatedNCT00296556Phase 2
- A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative ColitisCompletedNCT00295282Phase 1
- NBI With Magnification for Dysplasia Detection in Ulcerative ColitisStatus unknownNCT00292175Not applicable
- Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab StudyTerminatedNCT00279435Phase 2/3
- A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative ColitisTerminatedNCT00279422Phase 2/3
- Chromoendoscopy for Ulcerative Colitis SurveillanceCompletedNCT00274209
- New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative ColitisCompletedNCT00269438Phase 3
- Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative ColitisTerminatedNCT00268164Phase 2
- Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative ColitisCompletedNCT00267306Phase 1/2